EdgeRock Capital LLC Makes New $47,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

EdgeRock Capital LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 172 shares of the company’s stock, valued at approximately $47,000.

Other large investors have also added to or reduced their stakes in the company. Parkside Financial Bank & Trust grew its position in HCA Healthcare by 8.2% during the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after buying an additional 35 shares during the period. Wedmont Private Capital lifted its position in HCA Healthcare by 1.6% during the fourth quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock valued at $711,000 after purchasing an additional 39 shares in the last quarter. Creative Financial Designs Inc. ADV increased its position in HCA Healthcare by 19.9% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 253 shares of the company’s stock worth $68,000 after buying an additional 42 shares in the last quarter. Huntington National Bank lifted its position in shares of HCA Healthcare by 0.4% during the 3rd quarter. Huntington National Bank now owns 11,206 shares of the company’s stock valued at $2,756,000 after buying an additional 44 shares in the last quarter. Finally, Perigon Wealth Management LLC raised its stake in HCA Healthcare by 2.6% during the 4th quarter. Perigon Wealth Management LLC now owns 1,759 shares of the company’s stock worth $476,000 after acquiring an additional 44 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 1.6 %

Shares of HCA Healthcare stock traded down $5.03 on Wednesday, hitting $309.42. 1,023,674 shares of the company traded hands, compared to its average volume of 1,096,014. The stock’s 50 day moving average price is $321.53 and its 200-day moving average price is $298.85. The company has a market cap of $81.04 billion, a PE ratio of 15.42, a PEG ratio of 1.44 and a beta of 1.66. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $335.83. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter last year, the firm posted $4.93 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 20.74 EPS for the current year.

HCA Healthcare announced that its Board of Directors has approved a share buyback program on Tuesday, January 30th that permits the company to buyback $6.00 billion in shares. This buyback authorization permits the company to reacquire up to 7.4% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s board believes its stock is undervalued.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Activity at HCA Healthcare

In related news, SVP Chad J. Wasserman sold 344 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the completion of the transaction, the senior vice president now owns 2,452 shares in the company, valued at approximately $789,470.44. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the completion of the sale, the senior vice president now directly owns 1,576 shares in the company, valued at approximately $520,474. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Chad J. Wasserman sold 344 shares of the firm’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $321.97, for a total transaction of $110,757.68. Following the completion of the transaction, the senior vice president now directly owns 2,452 shares of the company’s stock, valued at approximately $789,470.44. The disclosure for this sale can be found here. Insiders have sold a total of 8,055 shares of company stock valued at $2,503,100 over the last quarter. 1.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

HCA has been the topic of several recent analyst reports. Oppenheimer raised their price objective on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research report on Monday, April 29th. TD Cowen cut their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a report on Friday, April 12th. Barclays upped their target price on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a research report on Monday, April 29th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a report on Wednesday, April 10th. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $316.59.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.